Transdermal delivery posts positive results
06 August, 2007 by Kate McDonaldApollo Life Sciences is testing its transdermal delivery technology in OTC applications before clinical trials for therapeutics.
No wilting in the face of Fusarium
27 July, 2007 by Joanne FinlayA NSW PhD student is looking at a cotton fungus to understand its interaction with other seedling pathogens.
Oncaidia goes public with mAb
26 July, 2007 by Kate McDonaldSA company offers IPO to further commercialise monoclonal antibody technology.
Pigs and pathogens: understanding antibiotic resistance
26 July, 2007 by Joanne FinlayResearch shows that the use of one antibiotic increases resistance but also increases the carriage of resistance genes against other classes of antibiotics.
PROFILE: Seek and we shall provide
25 July, 2007 by Kate McDonaldA Brisbane biomedical scientist has set up an online matching service for researchers. And before you ask, it's aimed at finding professional partners, not romantic ones.
Regular boost for high fibre research
25 July, 2007 by Staff WritersCSIRO and universities come together to research new grain varieties with higher fibre.
Microbicide well tolerated, even by men
24 July, 2007 by Staff WritersStarpharma's anti-HIV and herpes microbicide is well tolerated by men, the company told the IAS conference today.
Bioscience heading to Honkers
23 July, 2007 by External Press Release AuthorBioscience companies are invited to attend a trade mission to Hong Kong.
737 boosts leukaemia drugs
19 July, 2007 by Staff WritersStudy finds Abbott Laboratories' ABT-737 increases therapy effectiveness.
Biota starts RSV trial
17 July, 2007 by Staff WritersBiota and partner MedImmune begin antiviral trial for respiratory virus.
Starpharma's VivaGel on trial
10 July, 2007 by Kate McDonaldNIH-funded trial of Starpharma's VivaGel microbicide under way in US.
Monoclonal antibodies for Monash
05 July, 2007 by Staff WritersMonash University and Tecan to build monoclonal antibody production facility.
Cheers to beer and all things yeasty
02 July, 2007 by Kate McDonald500 international yeast biologists have descended on Melbourne.
Commercialisation bootcamp in Brisbane
28 June, 2007 by Staff Writers'Bootcamp' for Brisbane researchers interested in learning more about the business of commercialisation.
Giaconda begins hep C trial
27 June, 2007 by Staff WritersCombination therapy trial for refractory hep C begins.
